# Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia

> **NCT00114595** · PHASE4 · COMPLETED · sponsor: **University of Stellenbosch** · enrollment: 84 (—)

## Conditions studied

- Dyskinesia
- Schizophrenia

## Interventions

- **DRUG:** eicosapentaenoic acid

## Key facts

- **NCT ID:** NCT00114595
- **Lead sponsor:** University of Stellenbosch
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** 84 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114595, "Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00114595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*